23 May 2013
Keywords: acomplia, linked, five, deaths, uk, launch, french
Article | 09 June 2008
French drug major Sanofi-Aventis' obesity drug Acomplia (rimonabant) has been linked to five deaths and 720 adverse drug reactions in Britain
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2008
22 May 2013
© 2013 thepharmaletter.com